NCT04668521View on ClinicalTrials.gov

Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection

TerminatedOBSERVATIONAL
Enrollment

215

Participants

Timeline

Start Date

May 4, 2020

Primary Completion Date

December 15, 2023

Study Completion Date

December 15, 2023

Conditions
Adnexal MassGermline BRCA1 Gene MutationGermline BRCA2 Gene MutationHereditary Breast and Ovarian Cancer
Interventions
OTHER

OVA360

Multifactorial Risk Assessment for Breast \& Ovarian Cancer Risk Detection

Trial Locations (1)

78738

Silvana Franco, Austin

Sponsors
All Listed Sponsors
lead

Aspira Women's Health

INDUSTRY